Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.97 and traded as high as $1.79. Check-Cap shares last traded at $1.19, with a volume of 1,220,987 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on shares of Check-Cap in a report on Friday. They set a “sell” rating for the company.
View Our Latest Stock Report on CHEK
Check-Cap Stock Down 23.2 %
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Further Reading
- Five stocks we like better than Check-Cap
- Retail Stocks Investing, Explained
- Top 3 Investment Themes to Watch for in 2025
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.